CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 197 enrolled
Drug / intervention
iPad-based decision aid +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02991729
NCT02991729N/ACompleted

Use of a Novel Decision Aid for Prenatal Aneuploidy Screening

University of North Carolina, Chapel Hill·interventional·Posted Dec 13, 2016·Updated Oct 22, 2020

In Brief

A clinical study evaluating iPad-based decision aid and Genetic counseling appointment for Aneuploidy and Pregnancy Complications. Completed, enrolled 197 participants across 1 site.

Detailed Summary

The investigators aim to assess whether use of a novel, tablet-based computerized decision aid for aneuploidy screening is similar to routine care with a brief genetic counseling visit in improving patient knowledge and decreasing decisional conflict.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 13, 2016
Enrollment StartJan 20, 2017
Primary CompletionJan 5, 2018
Study CompletionJan 12, 2018
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 9.6 years ago

Interventions

iPad-based decision aidother

This is a novel decision aid developed by genetic counselors and Maternal Fetal Medicine physicians. It is used via an iPad and is interactive. It is available in English and Spanish has been piloted by 20 English and Spanish speaking women. It takes approximately 15 minutes to complete.

Genetic counseling appointmentother

All participants will undergo an approximately 15 minute educational genetic counseling appointment regarding aneuploidy screening options. Should family history concerns be identified on intake, this visit may be extended to include a discussion of additional issues.